Leukemia Cancer

A Phase III Randomized Trial of Arnesyl Transferase Inhibitor R115777 in Acute Myeloid Laukemia (AML) Patients in Second or Subsequesnt Remission or in Remission after Primary Induction Failure [ECOG 2902]

Principal Investigator:
Elyse Schneiderman, M.D.
Adventist Hinsdale Hospital
(630) 654-1790
Contact: Jan Wilson, R.N.

A Randomized Phase II Trial of Azacitidine with or without the Histone Deacetylase Inhibitor MS-275 for the Treatment of Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia (dysplastic type) and Acute Myeloid Leukemia with Multilineage Dysplasia [ECOG 1905]

Principal Investigator:
Elyse Schneiderman, M.D.
Adventist Hinsdale Hospital
(630) 654-1790
Contact: Jan Wilson, R.N.

Phase II Trial of Pentostatin, Cyclophosphamide and Rituximab (PCR) followerd by Campath-1H for Previously-Treated Relapsed or Refractory Patients  with Chronic Lymphocytic Leukemia [ECOG 2903]

Principal Investigator:
Elyse Schneiderman, M.D.
Adventist Hinsdale Hospital
(630) 654-1790